PharmEasy is India’s leading digital healthcare platform. It provides information, consultations, diagnostics tests, medicines, healthcare products, and services from registered and trusted pharmacies, leading diagnostic laboratories, and trusted doctors across India, serving every habitable zip code of the country. The journey of PharmEasy was started in 2015, when founders Dharmil Sheth, an MBA from IMT Ghaziabad and Dr. Dhaval Shah, MBBS from Rajiv Gandhi Medical College and MBA from XLRI Jamshedpur, came up with the idea of an online pharmacy to make healthcare affordable and accessible to one and all.
| P&L Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Revenue | 2335 | 5729 | 6644 | 5664 |
| Cost of Material Consumed | 2267 | 5342 | 5669 | 4737 |
| Gross Margins | 2.91 | 6.76 | 14.67 | 16.37 |
| Change in Inventory | -114 | -229 | 62 | 143 |
| Employee Benefit Expenses | 270 | 1459 | 1283 | 699 |
| Other Expenses | 482 | 1502 | 1051 | 731 |
| EBITDA | -570 | -2345 | -1421 | -646 |
| OPM | -24.41 | -40.93 | -21.39 | -11.41 |
| Other Income | 25 | -1185 | -2866 | 931 |
| Finance Cost | 43 | 258 | 666 | 728 |
| D&A | 33 | 159 | 243 | 216 |
| EBIT | -603 | -2504 | -1664 | -862 |
| EBIT Margins | -25.82 | -43.71 | -25.05 | -15.22 |
| PBT | -621 | -3977 | -5196 | -2522 |
| PBT Margins | -26.6 | -69.42 | -78.21 | -44.53 |
| Tax (2021) | 21 | 22 | 15 | 11 |
| PAT | -642 | -3999 | -5211 | -2533 |
| NPM | -27.49 | -69.8 | -78.43 | -44.72 |
| EPS | -25.08 | -6.51 | -8.48 | -3 |
| Financial Ratios | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Operating Profit Margin | -24.41 | -40.93 | -21.39 | -11.41 |
| Net Profit Margin | -27.49 | -69.8 | -78.43 | -44.72 |
| Earning Per Share (Diluted) | -25.08 | -6.51 | -8.48 | -3.9 |
| Assets | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Fixed Assets | 128 | 1025 | 912 | 734 |
| CWIP | 0.2 | 7.8 | 4 | 3.6 |
| Investments | 1 | 438 | 342 | 329 |
| Trade Receivables | 358 | 861 | 905 | 706 |
| Inventory | 406 | 761 | 688 | 556 |
| Other Assets | 4011.8 | 8305.2 | 5405 | 6061.4 |
| Total Assets | 4905 | 11398 | 8256 | 8390 |
| Liabilities | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Share Capital | 25.6 | 614.2 | 614.2 | 649.6 |
| FV | 1 | 1 | 1 | 1 |
| Reserves | 3555.4 | 6408.3 | 1823 | 1938 |
| Borrowings | 585 | 2585 | 4120 | 4098 |
| Trade Payables | 365 | 459 | 413 | 413 |
| Other Liabilities | 374 | 1331.5 | 1285.8 | 1291.4 |
| Total Liabilities | 4905 | 11398 | 8256 | 8390 |
| Cash-Flow Statement | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| PBT | -620 | -3971 | -5196 | -2522 |
| OPBWC | -427 | -1474 | -637 | -214 |
| Change in Receivables | -99 | -226 | -112 | 30 |
| Change in Inventories | -112 | -195 | 73 | 133 |
| Change in Payables | 74 | -18 | -45 | -0.5 |
| Other Changes | -238 | -592 | 39 | 26.5 |
| Working Capital Change | -375 | -1031 | -45 | 189 |
| Cash Generated From Operations | -802 | -2505 | -682 | -25 |
| Tax | -12 | -84 | -62 | -36 |
| Cash Flow From Operations | -814 | -2589 | -744 | -61 |
| Purchase of PPE | -31 | -143 | -95 | -72 |
| Sale of PPE | 1 | 5 | 8 | 10 |
| Cash Flow From Investment | 4 | -5789 | -72 | -1261 |
| Borrowing | 15 | 2016 | 652 | -231 |
| Divided | 0 | 0 | -23 | -29.5 |
| Equity | 399.2 | 6344 | 548 | 2000 |
| Others From Financing | 605.8 | -55 | -324 | -282.5 |
| Cash Flow from Financing | 1020 | 8305 | 853 | 1457 |
| Net Cash Generated | 210 | -73 | 37 | 135 |
| Cash at the Start | 20 | 230 | 157 | 192 |
| Cash at the End | 230 | 157 | 194 | 327 |
| Shareholding Pattern | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|
| Naspers Ventures B. V. | 0 | 13.24% | 13.24% | 13.03% |
| MacRitchie Investments Pte. Ltd. | 13.74% | 11.93% | 11.93% | 11.74% |
| Prasid Uno Family Trust Through Its Trustee Surbhi Singh | 13.18% | 6.10% | 6.10% | 4.39% |
| TPG Growth V SF Markets Pte. Ltd | 8.73% | 7.32% | 7.32% | 7.20% |
| Evermed Holdings Pte. Ltd. | 14.65% | 6.45% | 6.45% | 6.35% |
| Prasid Uno Family Trust Through Its Trustee Surbhi Singh | 13.18% | 6.10% | 6.10% | 4.39% |
| Others | 43.48% | 54.96% | 54.96% | 57.29% |
